Incorporating Treatment Advances for Metastatic Pancreatic Cancer Into Practice

Incorporating Treatment Advances for Metastatic Pancreatic Cancer Into Practice is organized by prIME oncology Oncology and will be held during Feb 28, 2017 - Feb 28, 2018.

The target audience for this medical event is designed for medical oncologists, gastroenterologists, and other healthcare providers involved in the management of patients with pancreatic cancer outside of the United States.

Topics:

• Introduction
• Factors to consider for treatment decision making
• First-line treatment strategies
• Selecting second-line therapy
• Managing toxicity of patients treated with nal-IRI/5-FU
• New treatment strategies

Conference Objectives are :

After successful completion of this educational activity, participants should be able to:
• Explain factors that impact treatment decision making in metastatic pancreatic adenocarcinoma
• Evaluate available and emerging therapies for metastatic pancreatic cancer
• Identify the best sequence of therapy for individual patients with metastatic pancreatic cancer

Additional details will be posted as soon as they are available.